Back to all news
AI Model Improves Differentiation of Brain Tumor Progression from Radiation Necrosis on MRI
A York University-led study shows a novel AI using advanced MRI can distinguish between progressive brain tumors and radiation necrosis more accurately than human assessment.
Key Details
- 1AI model uses attention-guided deep learning with chemical exchange saturation transfer (CEST) MRI.
- 2Study included over 90 patients with brain metastases treated by stereotactic radiosurgery (SRS).
- 3AI achieved over 85% accuracy in distinguishing tumor progression from necrosis, compared to ~60% for standard MRI and ~70% for advanced MRI alone.
- 4Published December 2025 in International Journal of Radiation Oncology, Biology, Physics.
- 5A crucial clinical challenge as treatment decisions for tumor progression vs necrosis are substantially different.
Why It Matters
Differentiating tumor progression from radiation necrosis on MRI post-therapy is a major clinical challenge, as each requires different treatments. AI that improves diagnosis accuracy could substantially impact patient management and outcomes in neuro-oncology.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.